Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
28.6%
% of PINK's 53 holdings also in HRTS
35.0%
% of HRTS's 41 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PINK |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 10.9% | 10.1% |
|
UNITEDHEALTH GROUP INC | 4.9% | 5.6% | 4.9% |
|
GILEAD SCIENCES INC | 5.0% | 3.1% | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% | 2.8% | 2.8% |
|
ABBVIE INC | 5.2% | 2.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to HRTS
|
ARCUTIS BIOTHERAPEUTICS INC | 7.6% |
|
JOHNSON & JOHNSON | 5.0% |
|
RESMED INC | 4.9% |
|
REGENERON PHARMACEUTICALS | 4.7% |
|
INTUITIVE SURGICAL INC | 4.4% |
|
DANAHER CORP | 3.2% |
|
PACIRA PHARMACEUTICALS INC | 3.1% |
|
PURECYCLE TECHNOLOGIES INC | 3.1% |
|
ABBVIE INC | 3.0% |
|
CIGNA CORPORATION | 2.8% |
PINK Underweight Relative to HRTS
|
BRIDGEBIO PHARMA, INC. | -4.3% |
 |
ASTRAZENECA PLC | -4.0% |
 |
NOVO NORDISK A/S-B | -3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.2% |
|
NOVARTIS AG | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.0% |
 |
MEDTRONIC PLC | -3.0% |
|
CRINETICS PHARMACEUTICALS INC | -2.8% |
|
MERCK & CO. INC. | -2.5% |